255 related articles for article (PubMed ID: 37462859)
1. Pancreatic steatosis and metabolic pancreatic disease: a new entity?
Caldart F; de Pretis N; Luchini C; Ciccocioppo R; Frulloni L
Intern Emerg Med; 2023 Nov; 18(8):2199-2208. PubMed ID: 37462859
[TBL] [Abstract][Full Text] [Related]
2. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
3. Fatty pancreas disease: clinical impact.
Blaho M; Dítě P; Kunovský L; Martínek A
Vnitr Lek; 2018; 64(10):949-952. PubMed ID: 30590942
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
5. Enlarged pancreas: not always a cancer.
Calculli L; Festi D; Pezzilli R
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):107-8. PubMed ID: 25655299
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Steatosis: An Emerging Clinical Entity.
Ramkissoon R; Gardner TB
Am J Gastroenterol; 2019 Nov; 114(11):1726-1734. PubMed ID: 31185002
[TBL] [Abstract][Full Text] [Related]
7. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of pancreatic steatosis.
Smits MM; van Geenen EJ
Nat Rev Gastroenterol Hepatol; 2011 Mar; 8(3):169-77. PubMed ID: 21304475
[TBL] [Abstract][Full Text] [Related]
9. PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY.
Paul J; Shihaz AVH
Arq Gastroenterol; 2020; 57(2):216-220. PubMed ID: 32490903
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
13. Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN).
Rebours V; Gaujoux S; d'Assignies G; Sauvanet A; Ruszniewski P; Lévy P; Paradis V; Bedossa P; Couvelard A
Clin Cancer Res; 2015 Aug; 21(15):3522-8. PubMed ID: 25700304
[TBL] [Abstract][Full Text] [Related]
14. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
Bi Y; Wang JL; Li ML; Zhou J; Sun XL
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
[TBL] [Abstract][Full Text] [Related]
15. Intra-pancreatic fat deposition: bringing hidden fat to the fore.
Petrov MS; Taylor R
Nat Rev Gastroenterol Hepatol; 2022 Mar; 19(3):153-168. PubMed ID: 34880411
[TBL] [Abstract][Full Text] [Related]
16. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging: Proton density fat fraction for assessment of pancreatic fatty infiltration during progression of T2DM bama minipigs.
Chen Y; Jiang Z; Long L; Miu Y; Zhang L; Zhong D; Tang Q
J Magn Reson Imaging; 2019 Dec; 50(6):1905-1913. PubMed ID: 31006935
[TBL] [Abstract][Full Text] [Related]
18. Fatty Pancreas: An Underappreciated Intersection of the Metabolic Profile and Pancreatic Adenocarcinoma.
Swislocki A
Metab Syndr Relat Disord; 2021 Aug; 19(6):317-324. PubMed ID: 33656378
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents.
Lee Y; Lingvay I; Szczepaniak LS; Ravazzola M; Orci L; Unger RH
Int J Obes (Lond); 2010 Feb; 34(2):396-400. PubMed ID: 20010902
[TBL] [Abstract][Full Text] [Related]
20. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes.
Kim MK; Chun HJ; Park JH; Yeo DM; Baek KH; Song KH; Chung DJ; Kwon HS
Diabetes Res Clin Pract; 2014 Dec; 106(3):590-6. PubMed ID: 25444353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
